Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2011
02/02/2011CN101965349A Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents
02/02/2011CN101962536A Lysosome targeted fluorescent substance and synthesis method thereof
02/02/2011CN101544650B Iodo-copper phthalocyanine nano-bar material and synthesizing method thereof
02/02/2011CN101440073B Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof
02/02/2011CN101362765B 5,7-diaminopyrazolo '4,3-d-pyrimidines with PDE-5 inhibiting activity
02/02/2011CN101137657B Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
02/01/2011US7880009 Cinnamide compound
02/01/2011US7879996 2-([60] fullerene [1',9':3,4] cyclohexen-1-y1)-5,10,15,20-(tetra magnesium [(4-(N-(4-carboxy butyl) amino) phenyl 2,3-dicarboxylatel]) porphyrin iron (II); prepared by linking a fullerene to a porphyrin compound, preferably with electromagnetic or sonic waves
02/01/2011US7879880 Substituted aniline derivatives useful as histamine H3 antagonists
02/01/2011US7879874 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis
02/01/2011US7879863 Aniline derivatives
02/01/2011US7879862 Central nervous system disorders; psychological disorders; anxiolytic agents; irritable bowel syndrome; antidepressants
02/01/2011US7879855 administering (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide, for the treatment of cancers of the colon, lung, ovary, and pancreas; anticarcinogenic agents
02/01/2011US7879851 Viral polymerase inhibitors
02/01/2011US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent
02/01/2011US7879492 redox system; lithium batteries; nontoxic; improved electroconductivity
02/01/2011CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
02/01/2011CA2481560C Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
02/01/2011CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11
02/01/2011CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure
02/01/2011CA2418656C Proline derivatives and use thereof as drugs
01/2011
01/27/2011WO2011011303A1 Inhibitors of flaviviridae viruses
01/27/2011WO2011011186A2 Hdac inhibitors and therapeutic methods using the same
01/27/2011WO2011010589A1 Fullerene derivative
01/27/2011WO2011010332A1 Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
01/27/2011WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
01/27/2011WO2011009695A1 New anti-angiogenic compounds
01/27/2011WO2010143803A3 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
01/27/2011WO2010104324A3 Halogenated isoindole compounds with superior binding affinity to beta-amyloid aggregates and fibrils, method for preparing same, and use thereof
01/27/2011WO2010096426A3 Compounds, compositions, methods of synthesis, and methods of treatment
01/27/2011WO2010088518A3 Heterocyclic modulators of gpr119 for treatment of disease
01/27/2011US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
01/27/2011US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
01/27/2011US20110021544 Hydrochloride salt of ((1s,2s,4r)-4--2-hydroxycyclopentyl)methyl sulfamate
01/27/2011US20110021543 Heterocyclic compounds and their use as pesticides
01/27/2011US20110021521 Fused heterocyclic compounds as ion channel modulators
01/27/2011US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases
01/27/2011US20110021518 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
01/27/2011US20110021513 Modulators of interleukin-1 receptor-associated kinase
01/27/2011US20110021511 Substituted 5h-pyrimido[5,4-b]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system
01/27/2011US20110021506 Anthelmintic agents and their use
01/27/2011US20110021495 Quinazoles useful as modulators of ion channels
01/27/2011US20110021479 Pyrrolopyrimidinecarboxamides
01/27/2011US20110021425 Tricyclic inhibitors of jak
01/27/2011US20110021351 Herbicidal compounds
01/27/2011US20110020276 Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors
01/27/2011US20110020275 Compounds for the Treatment of Hepatitis C
01/27/2011CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
01/27/2011CA2767088A1 Inhibitors of flaviviridae viruses
01/26/2011EP2277881A1 Heterocyclic compound having inhibitory activity on p13k
01/26/2011EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer
01/26/2011EP2276764A1 Compounds for the treatment of hepatitis c
01/26/2011EP2276763A1 Mtor inhibitor salt forms
01/26/2011EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders
01/26/2011EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
01/26/2011EP2276750A2 Substituted pyrimidines and triazines and their use in cancer therapy
01/26/2011EP2276725A1 New ruthenium complexes as catalysts for metathesis reactions
01/26/2011EP1697377B1 Polycyclic agents for the treatment of respiratory syncytial virus infections
01/26/2011EP1503979B1 Process for hydrogenating unactivated imines using ruthenium complexes as catalysts
01/26/2011CN1918128B Fused ring 4-oxopyrimidine derivative
01/26/2011CN1829521B Hydrolytically-resistant boron-containing therapeutics and methods of use
01/26/2011CN1726603B Charge transport compositions and electronic devices made with such compositions
01/26/2011CN101960637A Organic electroluminescent device
01/26/2011CN101959967A Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-get recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment
01/26/2011CN101959966A Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-get recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment
01/26/2011CN101959891A Method of synthesizing tetrahydrobiopterin
01/26/2011CN101959890A Pyrrolopyrimidinecarboxamides
01/26/2011CN101959889A Heterocyclic compounds as inhibitors of CXCR2
01/26/2011CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound
01/26/2011CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics
01/26/2011CN101955483A Synthetic method of 2-substituted [1,2,4] triazolo [1,5-a] benzimidazole
01/26/2011CN101006064B Method for preparing irbesartan and intermediates thereof
01/25/2011US7875716 Inhibitors of folic acid-dependent enzymes
01/25/2011US7875713 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof
01/25/2011US7875613 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
01/25/2011US7875612 Folate mimetics and folate-receptor binding conjugates thereof
01/25/2011CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives
01/25/2011CA2468681C Adenosine a2a receptor antagonists
01/25/2011CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof
01/25/2011CA2457856C Sulphonated meso-tetraphenyl chlorins and their use as therapeutic agents
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/25/2011CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use
01/20/2011WO2011008830A1 Pyrrolopyrazine inhibitors of kinases
01/20/2011WO2011008572A2 5-ht3 receptor modulators, methods of making, and use thereof
01/20/2011WO2011008312A2 Indole and indoline derivatives and methods of use thereof
01/20/2011WO2011008110A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
01/20/2011WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
01/20/2011WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound
01/20/2011WO2011007756A1 Heterocyclic compound and use thereof
01/20/2011WO2011007314A1 IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE
01/20/2011WO2011007180A1 Immunodetection and quantification of pyrazolopyrimidine sedatives
01/20/2011WO2011006936A1 Tricyclic indole-derived spiro derivatives as crth2 modulators
01/20/2011WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
01/20/2011WO2011006569A1 Heterocyclic compounds as autotaxin inhibitors
01/20/2011WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
01/20/2011WO2011006453A1 Compound lipid based on pentaerythritol, intermediates, preparation method and use thereof
01/20/2011WO2010109480A3 Processes for preparation of indiplon and intermediates thereof
01/20/2011WO2010102758A3 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
01/20/2011WO2010003475A8 Novel pyrrolidone derivatives for use as metap-2 inhibitors
01/20/2011US20110015300 Methods and systems for coating a surface